Monopar Therapeutics MNPR

$ 38.24 -7.61%

Quarterly report 2024-Q3
added 11-08-2024

Monopar Therapeutics EV/EBITDA Ratio 2011-2025 | MNPR

Annual EV/EBITDA Ratio Monopar Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-2.05	-11.6	-33.2	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-2.05	-33.2	-15.6